EVOX THERAPEUTICS LIMITED
Research and experimental development on biotechnology
EVOX THERAPEUTICS LIMITED
Research and experimental development on biotechnology
AI Analysis
AI Analysis
Analyze director networks, ownership patterns, and company connections
Sign in to access AI-powered company analysis
Sign InCompanyTrack AI can make mistakes. Check important info.
Contact & Details
Contact
Update DetailsRegistered Address
Medawar Centre 2nd Floor East Building Robert Robinson Avenue Oxford Oxfordshire OX4 4HG United Kingdom
Office (Oxford)
7200 Oxford Business Park, Oxford OX4 2JZ
Telephone
00441865819140Website
evoxtherapeutics.comCredit Report
Discover EVOX THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.
Mutual Companies
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Cash in Bank
£21.44M
Net Assets
£26.18M
Total Liabilities
£2.19M
Turnover
N/A
Employees
N/A
Debt Ratio
8%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Unlock 9 years of financial data
Sign up to view revenue, profit, assets and more
Funding
Fundraising & Grants
Investors (0)
No investor information available
Officers
Officers
| Status | ||
|---|---|---|
| Evan Samuel Caplan | Director | Active |
| Laura Ann Taylor Feinleib | Director | Active |
| Martin Andrews | Director | Active |
| Per Lundin | Director | Active |
| Sarah Lucinda Gordon Wild | Director | Active |
| Wallace Lucy Elizabeth Wallace | Director | Active |
Persons with Significant Control
Persons with Significant Control (1)
Oxford Science Enterprises Plc
United Kingdom
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Group Structure
Group Structure
Charges
Charges
No charges registered
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 6 Oct 2025 | Officers | Termination of Alex Eric Hammacher as director on 2025-09-09 | View(1 page) |
| 6 Oct 2025 | Officers | Appointment of Wallace Wallace as director on 2025-09-12 | View(2 pages) |
| 29 May 2025 | Capital | Allotment of shares (GBP 7,570.04) on 2025-05-27 | View(4 pages) |
| 2 May 2025 | Accounts | Annual accounts made up to 2024-12-31 | View(35 pages) |
| 22 Apr 2025 | Confirmation Statement | Confirmation statement made on 2025-03-16 with updates | View(7 pages) |
Termination of Alex Eric Hammacher as director on 2025-09-09
Confirmation statement made on 2025-03-16 with updates
Recent Activity
Latest Activity
Termination of Alex Eric Hammacher as director on 2025-09-09
4 months ago on 6 Oct 2025
Appointment of Wallace Wallace as director on 2025-09-12
4 months ago on 6 Oct 2025
Allotment of shares (GBP 7,570.04) on 2025-05-27
8 months ago on 29 May 2025
Annual accounts made up to 2024-12-31
9 months ago on 2 May 2025
Confirmation statement made on 2025-03-16 with updates
10 months ago on 22 Apr 2025